EP2540350 - COMBINATIONS OF A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR WITH OTHER HCV AGENTS [Right-click to bookmark this link] | |||
Former [2013/01] | Combinations of a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitors with other HCV agents | ||
[2013/38] | Status | No opposition filed within time limit Status updated on 27.03.2015 Database last updated on 26.04.2025 | Most recent event Tooltip | 29.04.2016 | Lapse of the patent in a contracting state New state(s): SM | published on 01.06.2016 [2016/22] | Applicant(s) | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065 / US | For all designated states MSD Italia S.r.l. Via Vitorchiano, 151 00189 Rome / IT | [2014/21] |
Former [2013/01] | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065 / US | ||
For all designated states Istituto di ricerche di Biologia Molecolare P. Angeletti S.R.L. Via Vitorchiano 151 CAP 00189 Rome / IT | Inventor(s) | 01 /
Harper, Steven IRBM Via Pontina Km 30.600 Pomezia I-00040 Rome / IT | 02 /
Summa, Vincenzo IRBM Via Pontina Km 30.600 Pomezia I-00040 Rome / IT | 03 /
Liverton, Nigel J. MERCK SHARP & DOHME CORP. 126 East Lincoln Avenue Rahway, NJ New Jersey 07065-0907 / US | 04 /
McCauley, John A. MERCK SHARP & DOHME CORP. 126 East Lincoln Avenue Rahway, NJ New Jersey 07065-0907 / US | [2013/01] | Representative(s) | Horgan, James Michael Frederic Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | [N/P] |
Former [2013/01] | Horgan, James Michael Frederic Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | Application number, filing date | 12181546.8 | 17.07.2009 | [2013/01] | Priority number, date | US20080135559P | 22.07.2008 Original published format: US 135559 P | [2013/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2540350 | Date: | 02.01.2013 | Language: | EN | [2013/01] | Type: | B1 Patent specification | No.: | EP2540350 | Date: | 21.05.2014 | Language: | EN | [2014/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 03.12.2012 | Classification | IPC: | A61P31/14, A61K38/06, A61K38/07, A61K38/08, C07K5/08, C07K5/10, C07K5/12 | [2013/01] | CPC: |
C07K5/0808 (EP,US);
C07D241/36 (KR);
A61K31/498 (KR);
A61P1/16 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/22 (EP);
A61P43/00 (EP);
C07D403/12 (KR)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2013/01] | Extension states | AL | 02.07.2013 | BA | 02.07.2013 | RS | 02.07.2013 | Title | German: | KOMBINATIONEN EINER MAKROCYCLISCHEN CHINOXALINVERBINDUNG, DIE EIN HCV-NS3-PROTEASEHEMMER IST, MIT ANDEREN HCV-MITTELN | [2013/38] | English: | COMBINATIONS OF A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR WITH OTHER HCV AGENTS | [2013/38] | French: | COMBINAISONS D'UN COMPOSÉ DE QUINOXALINE MACROCYCLIQUE QUI EST UN DES INHIBITEURS DE LA PROTÉASE HCV NS3 AVEC D'AUTRES AGENTS HCV | [2013/38] |
Former [2013/01] | Kombinationen einer makrocyclischen Chinoxalinverbindung, die ein HCV-NS3-Proteasehemmer ist, mit anderen HCV-Mitteln | ||
Former [2013/01] | Combinations of a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitors with other HCV agents | ||
Former [2013/01] | Combinaisons d'un composé de quinoxaline macrocyclique qui est un des inhibiteurs de la protéase HCV NS3 avec d'autres agents HCV | Examination procedure | 02.07.2013 | Examination requested [2013/33] | 22.08.2013 | Communication of intention to grant the patent | 02.01.2014 | Fee for grant paid | 02.01.2014 | Fee for publishing/printing paid | 07.02.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 08.04.2014 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09790553.3 / EP2310095 | Opposition(s) | 24.02.2015 | No opposition filed within time limit [2015/18] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 08.04.2014 | Request for further processing filed | 08.04.2014 | Full payment received (date of receipt of payment) Request granted | 22.04.2014 | Decision despatched | Fees paid | Renewal fee | 02.01.2013 | Renewal fee patent year 03 | 02.01.2013 | Renewal fee patent year 04 | 08.07.2013 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 21.05.2014 | SM | 21.05.2014 | [2016/22] |
Former [2016/21] | MC | 21.05.2014 | Documents cited: | Search | [AD]WO2008057209 (MERCK & CO INC [US], et al) | by applicant | US3480613 | WO9741211 | WO9822496 | WO9846630 | WO9907733 | WO9907734 | WO9938888 | WO9943691 | WO9950230 | GB2337262 | WO9964442 | WO0009543 | WO0025780 | WO0059929 | WO0100622 | WO0147883 | WO0160379 | WO0168663 | WO0177091 | WO0179246 | US6323180 | WO0190121 | WO0192282 | WO0204425 | WO0206246 | US2002019363 | WO0218404 | WO0220497 | WO0232920 | WO0248116 | WO0248172 | WO0248165 | WO02051425 | WO02057287 | WO02057425 | US2002107138 | WO02100415 | WO03026589 | WO03026675 | WO03068244 | WO03093290 | US2003236216 | WO2004000858 | WO2004002999 | WO2004003000 | WO2004002422 | US2004006007 | WO2004003138 | WO2004007512 | WO2004011478 | WO2004013300 | US2004063658 | WO2004028481 | US2004067901 | US6777392 | WO2005003147 | US2005038240 | WO2005016927 | WO2006021341 | WO2006102087 | WO2006119061 | WO2007015785 | WO2007016441 | WO2007148135 | WO2008051475 | WO2008051477 | WO2008051514 | WO2008057209 |